[1] |
ZHANG Jing, CHEN Xi, WANG Bin, FU Lei, LU Yu, CHEN Xiao-you.
Establishment of modified propidium monoazide (PMAxx)-quantitative PCR assay and its application for identification of antituberculosis drug activity
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 472-480.
|
[2] |
GAO Tian-hui,SHU Wei,GAO Jing-tao,LU Yu,LI Qi.
Analysis of clarithromycin resistance and its influencing factors in 254 patients with drug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(3): 259-265.
|
[3] |
CHEN Hao,WU Nan-nan,HU Wen-hui,YANG Zhong-jin.
Research progress of new targets for antituberculosis agents
[J]. Chinese Journal of Antituberculosis, 2020, 42(3): 286-292.
|
[4] |
WANG Jing,ZHANG Meng,HE Jian-qing.
Clostridium difficile-associated diarrhea caused by anti-tuberculosis drugs: a case report and literature review
[J]. Chinese Journal of Antituberculosis, 2020, 42(3): 293-296.
|
[5] |
QIU Lei,ZHANG Shao-yan,GUO Xiao-yan,FU Ji-you,TIAN Li-ming,ZHANG Hui-yong,LU Zhen-hui.
Clinical value of chemotherapy regimen and Qinbudan tablet on the retreatment of retreated smear-positive pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 108-114.
|
[6] |
WANG Xue-di,JIANG Feng,DAI Qian-lan,WANG Jing,WANG Dong-mei..
Comparative analysis on drug-induced liver injury of the combination of traditional Chinese and Western medicine and single Western medicine in tuberculosis treatment (Literature review 2000-2019)
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 126-132.
|
[7] |
LI Meng, LU Li-ping, JIANG Qi, HONG Jian-jun, GAO Qian, YANG Chong-guang, GUO Xiao-qin.
Analysis of the types and expense of therapeutic drugs for pulmonary tuberculosis in Songjiang District of Shanghai
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1329-1332.
|
[8] |
TANG Liang, BAO Yu-cheng, ZHANG Wen-long.
Effects of anti-tubercular agents on intestinal flora and its influence on the organism
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1333-1338.
|
[9] |
Xi CHEN,Zhong-quan LIU,Bin WANG,Hui ZHU,Lei FU,Yuan-yuan LI,Yu LU.
Evaluation of antituberculosis activities of 14 antituberculosis drugs in macrophage
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 993-998.
|
[10] |
Board of Chinese Journal of Antituberculosis Editorial.
Expert consensus on the solutions of drug side effects during the treatment of drug resistance tuberculosis
[J]. Chinese Journal of Antituberculosis, 2019, 41(6): 591-603.
|
[11] |
Guo-fang DENG,Pei-ze ZHANG,Min YANG,Liang FU.
Current knowledge and future prospects on the treatment of multidrug-resistant tuberculosis with second-line injectable agents
[J]. Chinese Journal of Antituberculosis, 2019, 41(6): 604-608.
|
[12] |
Jiao-jie ZHAO,Yu LU.
Research and progress of PK/PD for anti-tuberculosis drugs
[J]. Chinese Journal of Antituberculosis, 2019, 41(6): 700-704.
|
[13] |
Cun-bing GUO,Hui LI,Shu-lan ZHENG.
Treatment effect of Shenqi Eleven Granules on leuccytopenia caused by antituberculosis drugs
[J]. Chinese Journal of Antituberculosis, 2018, 40(3): 274-279.
|
[14] |
Wan-li KANG,Yang LIU,Shen-jie TANG,Su-hua. ZHENG.
Study on the association of different sites of tuberculous lesion in inpatients with tuberculosis from Tongzhou District, Beijing
[J]. Chinese Journal of Antituberculosis, 2018, 40(1): 94-97.
|
[15] |
XIA Lu, LU Shui-hua, LI Feng.
Clinical analysis on efficacy of BCG reactive lymph node phlogistic with cow mycobacteria vaccine
[J]. Chinese Journal of Antituberculosis, 2016, 38(3): 189-192.
|